Treatment of Moderately Enlarged SMV-IVC Portosystemic Shunt in Cirrhosis
For a moderately enlarged SMV-IVC spontaneous portosystemic shunt (SPSS) in a cirrhotic patient, embolization should be considered if the shunt is >6mm and the patient has refractory hepatic encephalopathy (HE), while shunts causing symptomatic HE should be embolized using balloon-occluded retrograde transvenous obliteration (BRTO) or other interventional techniques. 1
Clinical Decision Algorithm
Step 1: Assess for Hepatic Encephalopathy
- If patient has refractory HE (persistent despite medical therapy or ≥3 episodes requiring hospitalization in 3 months):
Step 2: Determine Embolization Technique
The evidence supports BRTO as the primary interventional approach for SMV-IVC shunts:
- BRTO has demonstrated effective management of HE while preserving hepatic function 2
- Alternative techniques include direct embolization under imaging guidance 3
- Surgical ligation is a backup option if interventional approaches fail 4
Step 3: Medical Management Considerations
Before intervention:
- Optimize medical therapy with lactulose for first-line HE treatment
- Add rifaximin if recurrent HE episodes occur 1
- Document baseline ammonia levels and HE grade
Post-intervention monitoring:
- Large SPSS (>6mm) are associated with increased mortality risk in cirrhosis 1
- Monitor for development of portal hypertensive complications after shunt closure
- If portal hypertension complications emerge post-embolization, consider small-caliber TIPS creation 1
Important Caveats
Risk-Benefit Assessment
The decision to embolize must weigh:
- Benefit: Resolution of debilitating HE symptoms
- Risk: Potential worsening of portal hypertension with development of varices, ascites, or bleeding after shunt closure
When NOT to Embolize
- Shunts <6mm without symptomatic HE
- Patients with active variceal bleeding (address bleeding first)
- Severe hepatic decompensation where increased portal pressure cannot be tolerated
Special Consideration for Asymptomatic Shunts
If the patient has a moderately enlarged SMV-IVC shunt but no HE symptoms, the 2022 North American guidelines suggest embolization may still be considered at the time of elective TIPS placement for other indications (ascites/hepatic hydrothorax) to prevent post-TIPS HE 1. However, for isolated asymptomatic shunts, observation with medical optimization is reasonable.
Monitoring After Embolization
- Serial imaging to confirm shunt occlusion
- Clinical assessment for HE improvement (typically within days to weeks)
- Surveillance for new portal hypertensive complications
- Endoscopic screening for varices if not previously performed
The evidence strongly supports that large SPSS contribute to both HE and mortality in cirrhosis, making intervention appropriate when shunts are >6mm and symptomatic 1. The case reports demonstrate technical feasibility and clinical success with BRTO specifically for SMV-IVC shunts 3, 2.